Cargando…
DAXX inhibits cancer stemness and epithelial–mesenchymal transition in gastric cancer
BACKGROUND: DAXX is a transcription repressor that has been implicated in several types of cancers, but its role in the development of gastric cancer remains unknown. METHODS: We analysed the expression of DAXX in 83 pairs of gastric cancer samples, including neoplastic and adjacent tissues, and cor...
Autores principales: | Wu, Chaofan, Ding, Hui, Wang, Shuochen, Li, Yangxin, Liu, Song-Bai, Wang, Xiaoxiao, Zheng, Jiqing, Xue, Ting, Amin, Hesham M., Song, Yao-Hua, Zhou, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217831/ https://www.ncbi.nlm.nih.gov/pubmed/32203224 http://dx.doi.org/10.1038/s41416-020-0800-3 |
Ejemplares similares
-
Zyxin inhibits the epithelial–mesenchymal transition process in gastric cancer by upregulating SIRT1
por: Lou, Jing, et al.
Publicado: (2023) -
Prognostic significance of Daxx NCR (Nuclear/Cytoplasmic Ratio) in gastric cancer
por: Xu, Jian‐feng, et al.
Publicado: (2017) -
FZD5 prevents epithelial-mesenchymal transition in gastric cancer
por: Dong, Dan, et al.
Publicado: (2021) -
Effects of PLK1 on proliferation, invasion and metastasis of gastric cancer cells through epithelial-mesenchymal transition
por: Song, Rui, et al.
Publicado: (2018) -
Aquaporin 3 promotes epithelial-mesenchymal transition in gastric cancer
por: Chen, Jia, et al.
Publicado: (2014)